Project Overview
Shivom OMX
Shivom is powering the next era of genomics through blockchain technology
Ticker
OMX
Country
United Kingdom
Website
Contact Email
henryines@yahoo.com
White paper
Platform
Total Supply
3000000000 OMX
Social Media
Medium
Bitcointalk
Telegram
Google Plus
–
Slack
YouTube Channel
Discord
Github
–
Steemit
–
–
Project Description
Description
Shivom is powering the next era of genomics through blockchain technology – by protecting identity, personalizing healthcare, transforming lives. Our blockchain based genomics and healthcare platform will allow the transition to value-based precision healthcare. Our focus is on the transformational convergence of OMICS technologies with blockchain, artificial intelligence and machine learning to enable secure and personalized medicine with global scalability.
We envision a future where genomic data becomes ubiquitous, with its insights for enhancing healthcare securely available and accessible to all. Shivom is pioneering the omics ecosystem to make this vision a reality by offering a first-of-its-kind investment proposition in the rapidly growing market for personalized medicine, powered by state-of-the-art blockchain technology.
We will additionally build a state-of-the art and not-for-profit drug discovery and precision medicine organization. Shivom researchers will use data-driven tools and techniques, particularly machine learning methods that underpin artificial intelligence, which will offer promise in improving healthcare systems and services around the globe.
Blockchain technology is our tech partner of choice because it is able to address trust issues, including patient consent, data ownership, data integrity, and authentication.
Blockchain can also manage complex data rights and allow finegrained access using smart contracts.
ICO Overview
Ticker
OMX
Accepted Payment Methods
MVP?
KYC/Whitelist
KYC & Whitelist
Soft Cap
12960
Hard Cap
64802
Restricted Countries
Bounty Program
–
Airdrop Overview
Current Status: Unknown
Description
–
Amount Available
–
Start Date
–
End Date
–
Private-Sale Overview
Current Status: Unknown
Private Sale Price
–
Private Sale Goal
–
Private Sale Min Contribution
–
Private Sale Available for Sale
–
Private Sale Start Date
–
Private Sale End Date
–
Pre-Sale Overview
Current Status: Unknown
Price
–
Goal
–
Minimum Contribution
–
Available for Pre-Sale
–
Pre-Sale Start Date
–
Pre-Sale End Date
–
Public Sale Overview
Current Status: Complete
Public Sale Price
7142
Available For Sale
990000000 OMX
Public Sale Minimum Contrabution
–
Public Sale Start Date
April 16, 2018
Public Sale End Date
May 16, 2018
Team Members
Dr. Axel Schumacher
Co-Founder & CEO
Gourish Singla
Co-Founder & COO
Sally Eaves
Co-Founder & CMO
Per Lind
Co-Founder & CSO
Akash Gaurav
Co-Founder & CTO
Henry Ines
Chief Innovation Officer
Agam Kansal
VP Marketing
Project Advisors
Kumar Gaurav
Co-Founder & Chief Technology Advisor